RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Receptor-binding hydrogen–deuterium exchange mass spectrometry as an additional measurement of biosimilarity

        Treuheit Nicholas A.,Crawford Nicholas F.,Maki Steven,Payne Jason,Allen Jeff 한국약제학회 2020 Journal of Pharmaceutical Investigation Vol.50 No.4

        Purpose Biosimilars can effectively reduce the cost of healthcare by providing a new source of competition for original drugs. A cornerstone of biosimilar development is assembling a comprehensive package of analytical data that demonstrates physicochemical biosimilarity to justify a shorter regimen of clinical trials. The purpose of the present work was to present part of a biosimilarity data package comparing Pfenex pegfilgrastim to its reference, Amgen’s Neulasta™ and to highlight a deuterium exchange experiment that can be used as part of the analytical tool box to demonstrate biosimilarity. Methods We used circular dichroism (CD), fluorescence, biolayer interferometry (BLI), and hydrogen–deuterium exchange (HDX) mass spectrometry experiments to analyze structural similarity between Pfenex pegfilgrastim and its reference, Amgen’s Neulasta™. In particular, we incorporated a novel HDX experiment comparing binding to the receptor by Pfenex pegfilgrastim or Neulasta™. Results The characterization experiments showed a high degree of similarity between the molecules, from secondary structure (CD/fluorescence), binding (BLI), and deuterium uptake in free and bound forms (HDX). Notably, the receptor-binding experiment found seven peptides that were similarly protected upon binding to both pegfilgrastim molecules. Conclusion These select experiments are a subset of the required characterization to demonstrate similarity, but they represent a progression of structural analysis that is enhanced and strengthened by a novel HDX experiment. This method improves our understanding of this interaction and gives us another analytical tool for demonstrating biosimilarity that should be adaptable for use with other biosimilar products in the future.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼